Green tea flavonoid may prevent reinfection with hepatitis C virus following …EurekAlert (press release)HCV is one of the most common causes of chronic liver disease and a primary indication for liver transplantation, affecting up to 170 million indi…
Department of DefenseNavy Officer Donates Marrow, Saves LifeDepartment of DefenseNavy Lt. Cmdr. John T. Schofield goes through final preparations for bone marrow transplant surgery at Georgetown University Medical Center, Washington, DC, Nov. 21, 2011….
Everolimus Prolongs Progression-Free SurvivalBiomed Middle EastBy jamal, on December 1st, 2011 The treatment combination of everolimus and octreotide long-acting repeatable (LAR), a somatostatin analogue that has shown antitumor activity, led to a clin…
Insiders are Selling These Stocks on Dec-1Beacon Equity Research… Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplan…
Donor drive to help Windsor resident's battle against cancer slated from 11 am …Greeley TribuneRaisley underwent a stem cell transplant using her own cells, but the cancer has returned a year later, said Sylvia Thomas, a longtime friend of Raisle…
Akron Leader PublicationsFairlawn man hits 16-gallon blood donation milestoneAkron Leader PublicationsFAIRLAWN — Local resident Sam Hamilton has saved the lives of hundreds of people — and all he had to do was sit back, relax and roll up a sleeve. …
Reimbursement in Personalized MedicineGenetic Engineering News“Gaining FDA clearance for AlloMap® (a noninvasive assay to manage the risk of heart transplant rejection) did nothing for reimbursement or clinical adoption. Instead, outcome studies to …
Global Hospitals to organise International Liver Conclave from Dec 2 to 4 in …pharmabiz.comThis three day scientific conference will be spearheaded by the world renowned Liver transplantation surgeon professor Mohamed Rela. Over 30 eminent doctors fr…
ifaonline.co.ukNICE gives green light to cancer drugHealth Insurance and Protection MagazineRituximab (marketed as MabThera by Roche) is a targeted therapy prescribed to people with follicular lymphoma, in combination with chemotherapy treatments. Evid…
ifaonline.co.ukNICE draft "yes" for MabThera, "no" to GilenyaPharma TimesEvidence shows that adding MabThera to chemotherapy treatments cyclophosphamide, vincristine and prednisolone (CVP), cyclophosphamide, doxorubicin, vincristine…